These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2076729)

  • 1. Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia.
    Patsalos PN; Elyas AA; Zakrzewska JM
    Eur J Clin Pharmacol; 1990; 39(4):413-5. PubMed ID: 2076729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):472-6. PubMed ID: 2738589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations.
    Kristensen O; Klitgaard NA; Jönsson B; Sindrup S
    Acta Neurol Scand; 1983 Sep; 68(3):145-50. PubMed ID: 6650125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Pain; 2002 Feb; 95(3):259-266. PubMed ID: 11839425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of saliva for monitoring oxcarbazepine therapy in epileptic patients.
    Klitgaard NA; Kristensen O
    Eur J Clin Pharmacol; 1986; 31(1):91-4. PubMed ID: 3780834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol.
    von Unruh GE; Paar WD
    Biomed Environ Mass Spectrom; 1986 Dec; 13(12):651-6. PubMed ID: 2952188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
    Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
    J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependent enzyme induction by oxcarbazepine?
    Patsalos PN; Zakrzewska JM; Elyas AA
    Eur J Clin Pharmacol; 1990; 39(2):187-8. PubMed ID: 2253672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects.
    Volosov A; Xiaodong S; Perucca E; Yagen B; Sintov A; Bialer M
    Clin Pharmacol Ther; 1999 Dec; 66(6):547-53. PubMed ID: 10613609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of 10-hydroxy carbazepine in blood compartments.
    Jung H; Noguez A; Mayet L; Fuentes I; González-Esquivel DF
    Biopharm Drug Dispos; 1997 Jan; 18(1):17-23. PubMed ID: 9008266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
    Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E
    Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma.
    von Unruh GE; Paar WD
    J Chromatogr; 1985 Nov; 345(1):67-76. PubMed ID: 4086590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs used in the management of trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):439-50. PubMed ID: 1408017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother.
    Bülau P; Paar WD; von Unruh GE
    Eur J Clin Pharmacol; 1988; 34(3):311-3. PubMed ID: 3396622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world effectiveness and tolerability of carbamazepine and oxcarbazepine in 354 patients with trigeminal neuralgia.
    Di Stefano G; De Stefano G; Leone C; Di Lionardo A; Di Pietro G; Sgro E; Mollica C; Cruccu G; Truini A
    Eur J Pain; 2021 May; 25(5):1064-1071. PubMed ID: 33428801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.
    Larkin JG; McKee PJ; Forrest G; Beastall GH; Park BK; Lowrie JI; Lloyd P; Brodie MJ
    Br J Clin Pharmacol; 1991 Jan; 31(1):65-71. PubMed ID: 2015172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
    Mogensen PH; Jórgensen L; Boas J; Dam M; Vesterager A; Flesch G; Jensen PK
    Acta Neurol Scand; 1992 Jan; 85(1):14-7. PubMed ID: 1546529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers.
    Theisohn M; Heimann G
    Eur J Clin Pharmacol; 1982; 22(6):545-51. PubMed ID: 7128666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.